Table 1.
Tissue source
|
Non-COVID-19 autopsy samples
|
COVID-19 autopsy samples
|
Total number of analyzed samples
|
Lung | H1Lu; H2Lu; H3Lu; H4Lu | Case1: Samples 1, 2, 3, 4; Case2: Samples 1, 2, 3; Case3: Samples 1, 2; Case4: Samples 1, 2; Case5: Samples 1, 2, 3, 4, 5; Case6: Samples 1, 2, 3, 4, 5; Case7: Samples 1, 2, 3, 4, 5; Case8: Samples 1, 2, 3, 4, 5; Case9: Samples 1, 2, 3, 4, 5; Case10: Samples 1, 2, 3; Case11: Samples 1, 2, 3 | 4 healthy samples and 42 COVID-19 samples |
Liver | H1Li; H2Li; H3Li; H4Li | Case3: Sample 1; Case4: Sample 1; Case5: Sample 1; Case8: Sample 1; Case10: Sample 1; Case12: Sample1 | 4 healthy samples and 6 COVID-19 samples |
COVID-19: Coronavirus disease 2019.